No abstract available
MeSH terms
-
Adenocarcinoma / drug therapy
-
Animals
-
Antineoplastic Agents / therapeutic use
-
Breast Neoplasms / drug therapy
-
Carcinoma, Bronchogenic / drug therapy
-
Carcinoma, Squamous Cell / drug therapy
-
Chemical Phenomena
-
Chemistry
-
Doxorubicin / administration & dosage
-
Doxorubicin / therapeutic use*
-
Doxorubicin / toxicity
-
Drug Combinations
-
Drug Evaluation
-
Female
-
Gastrointestinal Neoplasms / drug therapy
-
Hodgkin Disease / drug therapy
-
Humans
-
Leukemia L1210 / drug therapy
-
Lung Neoplasms / drug therapy
-
Male
-
Melanoma / drug therapy
-
Mice
-
Multiple Myeloma / drug therapy
-
Neoplasms / drug therapy*
-
Neuroblastoma / drug therapy
-
Ovarian Neoplasms / drug therapy
-
Prostatic Neoplasms / drug therapy
-
Sarcoma / drug therapy
-
Stomatitis / chemically induced
-
Testicular Neoplasms / drug therapy
-
Thyroid Neoplasms / drug therapy
-
Urinary Bladder Neoplasms / drug therapy
-
Uterine Neoplasms / drug therapy
Substances
-
Antineoplastic Agents
-
Drug Combinations
-
Doxorubicin